Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY37.76 CNY
Change Today +1.07 / 2.92%
Volume 4.8M
600211 On Other Exchanges
Symbol
Exchange
Shanghai
As of 2:03 AM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

tibet rhodiola pharm-a (600211) Snapshot

Open
CNY37.00
Previous Close
CNY36.69
Day High
CNY38.46
Day Low
CNY36.21
52 Week High
05/21/15 - CNY60.17
52 Week Low
10/9/14 - CNY30.05
Market Cap
5.5B
Average Volume 10 Days
5.4M
EPS TTM
CNY0.17
Shares Outstanding
145.6M
EX-Date
06/1/15
P/E TM
221.1x
Dividend
CNY0.05
Dividend Yield
0.13%
Current Stock Chart for TIBET RHODIOLA PHARM-A (600211)

Related News

No related news articles were found.

tibet rhodiola pharm-a (600211) Related Businessweek News

No Related Businessweek News Found

tibet rhodiola pharm-a (600211) Details

Tibet Rhodiola Pharmaceutical Holding Company is engaged in the production and distribution of pharmaceuticals in China. The company wholesales pharmaceuticals, as well as distributes proprietary drug products. It has operations primarily in southwest China, Beijing, Shanghai, Guangdong province, and other regions. The company was founded in 1999 and is based in Lhasa, China.

Founded in 1999

tibet rhodiola pharm-a (600211) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tibet rhodiola pharm-a (600211) Key Developments

Tibet Rhodiola Pharmaceutical Holding Co. Announces Earnings Results for the First Half of 2015

Tibet Rhodiola Pharmaceutical Holding Co. announced earnings results for the first half of 2015. For the first half, the company reported basic earnings per share of CNY 0.168 and weighted average return on net assets of 5.91%.

Tibet Rhodiola Pharmaceutical Holding Company, Board Meeting, Jul 28, 2015

Tibet Rhodiola Pharmaceutical Holding Company, Board Meeting, Jul 28, 2015. Agenda: To consider and approve the proposal of scheme for selling significant assets; to consider and approve the proposal of signing supplementary agreement on extending service agreement on new active element and nuodikang; and to consider the proposal of nomination of candidate for director.

Tibet Rhodiola Pharmaceutical Holding Company to Amend its Articles of Association

Tibet Rhodiola Pharmaceutical Holding Company in its EGM to be held on August 13, 2015, proposed to amend its articles of association.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600211:CH CNY37.80 CNY +1.11

600211 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600211.
View Industry Companies
 

Industry Analysis

600211

Industry Average

Valuation 600211 Industry Range
Price/Earnings 100.0x
Price/Sales 2.8x
Price/Book 12.3x
Price/Cash Flow 208.6x
TEV/Sales 2.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIBET RHODIOLA PHARM-A, please visit www.xzyy.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.